T

Therini Bio, Inc. (formerly MedaRed, Inc.)

3 employees

Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics
Medical

Date founded

2016

Funding rounds raised

Total raised

$36M

from 11 investors over 11 rounds

T

Therini Bio, Inc. (formerly MedaRed, Inc.) raised $36M on April 27, 2023

Investors: Sanofi Ventures, The Dementia Discovery Fund, SV Life Sciences and Dolby Family Ventures

T

Therini Bio, Inc. (formerly MedaRed, Inc.) raised $3M on January 1, 2023

Investors: National Institutes of Health

T

Therini Bio, Inc. (formerly MedaRed, Inc.) raised $17M on May 10, 2021

Investors: Sanofi Ventures, The Dementia Discovery Fund, Dolby Family Ventures and SV Life Sciences

T

Therini Bio, Inc. (formerly MedaRed, Inc.) raised $9.4M on July 8, 2019

Investors: The Dementia Discovery Fund and Dolby Family Ventures

FAQ